Merck & Co. Inc. MRK
What this company does
Written from the business description in Merck & Co., Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.
Revenue compounded at +9.4% a year over five years — but profit grew faster: net income at +20.9%, earnings per share at +21.2%.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Each USD of equity produced 37 cents of profit this year.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 65.0 | 64.2 | 60.1 | 59.3 | 48.7 | 41.5 | 39.1 | 42.3 | 40.1 | 39.8 | 39.5 | 42.2 | 44.0 | 47.3 | 48.0 | 46.0 | 27.4 | 23.9 | 24.2 |
| Operating income $B | 21.1 | 19.9 | 1.9 | 16.4 | 13.9 | 5.9 | 7.2 | 8.7 | 6.5 | 4.7 | 5.4 | 17.3 | 5.5 | 8.7 | 7.3 | 1.7 | 15.3 | · | · |
| EBITDA $B | 24.1 | 22.0 | 3.7 | 18.3 | 15.5 | 7.5 | 8.8 | 10.1 | 11.2 | 10.1 | 11.8 | 24.0 | 12.5 | 15.7 | 14.8 | 9.0 | 17.9 | · | · |
| Income tax $B | 2.8 | 2.8 | 1.5 | 1.9 | 1.5 | 1.3 | 1.6 | 2.5 | 4.1 | 0.7 | 0.9 | 5.3 | 1.0 | 2.4 | 0.9 | 0.7 | 2.3 | 2.0 | 0.1 |
| Net income $B | 18.3 | 17.1 | 0.4 | 14.5 | 13.0 | 7.1 | 9.8 | 6.2 | 2.4 | 3.9 | 4.4 | 11.9 | 4.4 | 6.2 | 6.3 | 0.9 | 12.9 | 7.8 | 3.3 |
| Free cash flow $B | 12.4 | 18.1 | 9.1 | 14.7 | 8.7 | 3.2 | 5.5 | 8.3 | 4.6 | 8.8 | 11.3 | 6.7 | 10.1 | 8.1 | 10.7 | 9.1 | 1.9 | 5.3 | 6.0 |
| EPS, diluted $ | 7.28 | 6.74 | 0.14 | 5.71 | 5.14 | 2.78 | 3.81 | 2.32 | 0.87 | 1.41 | 1.56 | 4.07 | 1.47 | 2.00 | 2.02 | 0.28 | 5.65 | 3.63 | 1.49 |
| Dividend / sh $ | 3.28 | 3.12 | 2.96 | 2.80 | 2.64 | 2.48 | 2.26 | 1.99 | 1.89 | 1.85 | 1.81 | 1.77 | 1.73 | 1.69 | 1.56 | 1.52 | 1.52 | 1.52 | 1.52 |
| Payout % | 45 | 46 | 2040 | 48 | 51 | 88 | 58 | 83 | 216 | 131 | 115 | 43 | 117 | 83 | 75 | 550 | 25 | 42 | 101 |
| ROE % | 36.9 | 40.8 | 0.9 | 34.5 | 41.1 | 27.6 | 37.4 | 20.4 | 6.4 | 9.2 | 9.5 | 24.2 | 8.6 | 11.5 | 11.5 | 1.5 | 33.2 | 41.6 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
This company against its peers
Reconciled in 19 of 19 fiscal years. 3 checks could not be computed.